PRAXIS PRECISION MEDICINES, INC. Debt Securities, Available-for-sale
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Debt Securities, Available-for-sale of $239.64 million as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-11-05
- 2025-09-30: Debt Securities, Available-for-sale $239.64M.
- 2025-06-30: Debt Securities, Available-for-sale $289.23M.
- 2025-03-31: Debt Securities, Available-for-sale $306.46M.
- 2024-12-31: Debt Securities, Available-for-sale $254.16M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2025-09-30 | $239.64M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $289.23M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $306.46M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $254.16M 10-Q · filed 2025-11-05 |
| 2024-09-30 | $242.53M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $306.91M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $123.66M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.98M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $38.87M 10-K · filed 2024-03-05 |
| 2022-09-30 | $61.30M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $109.36M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $144.66M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $137.21M 10-K · filed 2023-02-07 |
| 2021-09-30 | $148.69M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $163.31M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $139.66M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |